These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8448921)

  • 1. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.
    de Fijter CW; Verbrugh HA; Peters ED; Oe PL; van der Meulen J; Verhoef J; Donker AJ
    Clin Nephrol; 1993 Feb; 39(2):75-80. PubMed ID: 8448921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo.
    de Fijter CW; Verbrugh HA; Peters ED; Oe PL; van der Meulen J; Donker AJ; Verhoef J
    Adv Perit Dial; 1991; 7():150-3. PubMed ID: 1680413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo.
    de Fijter CW; Verbrugh HA; Oe PL; Peters ED; van der Meulen J; Donker AJ; Verhoef J; Lameire N
    Adv Perit Dial; 1991; 7():154-7. PubMed ID: 1680414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?
    de Fijter CW; Verbrugh HA; Oe PL; Heezius EC; Verhoef J; Donker AJ
    Nephrol Dial Transplant; 1994; 9(2):156-62. PubMed ID: 8190329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of amino-acid-based versus glucose-based continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Schenk U; Kiefer T; Hübel E; Weber J; Mettang T; Passlick-Deetjen J; Kuhlmann U
    Nephron; 1994; 68(3):338-46. PubMed ID: 7838257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Barocci S; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():110-3. PubMed ID: 1982785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
    Jones S; Holmes CJ; Mackenzie RK; Stead R; Coles GA; Williams JD; Faict D; Topley N
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CAPD dialysate on the release of eicosanoids and cytokines from human peritoneal macrophages.
    Steinhauer HB; Brugger U; Atmanspacher R; Lubrich-Birkner I; Schollmeyer P
    Adv Perit Dial; 1992; 8():47-52. PubMed ID: 1361851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
    de Fijter CW; Verbrugh HA; Heezius HC; van Bronswijk H; van der Meulen J; Oe PL; Donker AJ; Verhoef J
    Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function.
    Mackenzie RK; Jones S; Moseley A; Holmes CJ; Argyle R; Williams JD; Coles GA; Pu K; Faict D; Topley N
    Am J Kidney Dis; 2000 Jan; 35(1):112-21. PubMed ID: 10620552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Fischer FP; Schenk U; Kiefer T; Hübel E; Thomas S; Yatzidis H; Mettang T; Kuhlmann U
    Am J Kidney Dis; 1995 Dec; 26(6):924-33. PubMed ID: 7503067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.
    Brulez HF; Dekker HA; Oe PL; Verbeelen D; ter Wee PM; Verbrugh HA
    Nephron; 1996; 74(1):26-32. PubMed ID: 8883016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of low-calcium peritoneal dialysis solutions on peritoneal macrophage functions.
    Kiefer T; Schenk U; Hübel E; Weber J; Mettang T; Passlick-Deetjen J; Kuhlmann U
    Am J Kidney Dis; 1995 May; 25(5):751-60. PubMed ID: 7747729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.
    van Bronswijk H; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):368-73. PubMed ID: 3137037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Nephrol Dial Transplant; 1987; 2(2):104-8. PubMed ID: 3112647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-calcium peritoneal dialysis fluid should not impact peritonitis rates in continuous ambulatory peritoneal dialysis.
    de Fijter CW; Oe LP; Heezius EC; Donker AJ; Verbrugh HA
    Am J Kidney Dis; 1996 Mar; 27(3):409-15. PubMed ID: 8604711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
    Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
    Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid.
    de Fijter CW; Verbrugh HA; Oe LP; Heezius E; Donker AJ; Verhoef J; Gokal R
    Am J Kidney Dis; 1993 Apr; 21(4):411-8. PubMed ID: 8465822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.